CRNX Crinetics Pharmaceuticals In

held by 1 manager in Q4 2024

Manager	% of their portfolio	Held	Activity	Value	Shares
Stanley Druckenmiller Duquesne Family Office	0.18%	1.0 yr	Reduce 60.3%	$6M	122,700

Search